[go: up one dir, main page]

WO2000067708A3 - Compositions d'hormones steroides a administration orale et methodes d'utilisation - Google Patents

Compositions d'hormones steroides a administration orale et methodes d'utilisation Download PDF

Info

Publication number
WO2000067708A3
WO2000067708A3 PCT/US2000/012404 US0012404W WO0067708A3 WO 2000067708 A3 WO2000067708 A3 WO 2000067708A3 US 0012404 W US0012404 W US 0012404W WO 0067708 A3 WO0067708 A3 WO 0067708A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
steroidal hormone
hormone compositions
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/012404
Other languages
English (en)
Other versions
WO2000067708A2 (fr
Inventor
Vassem Ali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Priority to AU48252/00A priority Critical patent/AU4825200A/en
Publication of WO2000067708A2 publication Critical patent/WO2000067708A2/fr
Publication of WO2000067708A3 publication Critical patent/WO2000067708A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Cette invention concerne des compositions dentifrices comprenant une dose efficace d'oestrogène ou de substance renfermant un l'oestrogène. L'invention porte également sur diverses méthodes d'utilisation de ces compositions, notamment à titre prophylactique ou préventif en cas de perte de dents ou d'ostéoporose, ainsi que sur des kits thérapeutiques contenant une ou plusieurs de ces compositions.
PCT/US2000/012404 1999-05-07 2000-05-05 Compositions d'hormones steroides a administration orale et methodes d'utilisation Ceased WO2000067708A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48252/00A AU4825200A (en) 1999-05-07 2000-05-05 Oral steroidal hormone compositions and methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13308599P 1999-05-07 1999-05-07
US60/133,085 1999-05-07

Publications (2)

Publication Number Publication Date
WO2000067708A2 WO2000067708A2 (fr) 2000-11-16
WO2000067708A3 true WO2000067708A3 (fr) 2001-02-08

Family

ID=22456942

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/012404 Ceased WO2000067708A2 (fr) 1999-05-07 2000-05-05 Compositions d'hormones steroides a administration orale et methodes d'utilisation

Country Status (2)

Country Link
AU (1) AU4825200A (fr)
WO (1) WO2000067708A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040022A1 (fr) * 2000-11-17 2002-05-23 Warner-Lambert Company Llc Traitement des dysfonctionnement sexuels par l'antagoniste de la bombesine
PL367094A1 (en) 2001-07-31 2005-02-21 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
JP2022548314A (ja) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法
US12426782B2 (en) 2020-11-06 2025-09-30 The Board Of Trustees Of The Leland Stanford Junior University Systems and temporal alignment methods for evaluation of gestational age and time to delivery

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058564A (en) * 1979-09-07 1981-04-15 Horton J E Pharmaceutical compositions comprising anti-osteoporotic agents
EP0345039A2 (fr) * 1988-05-31 1989-12-06 AMER & COMPANY, INC. Procédé et composition pour le traitement ou la prévention de la plaque ou du tartre dentaires ou de la gingivite
EP0455503A1 (fr) * 1990-05-04 1991-11-06 Colgate-Palmolive Company Composition pour le traitement de l'ostéoporose et du déséquilibre hormonal
US5310545A (en) * 1991-04-11 1994-05-10 Drore Eisen Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter
WO1994016673A1 (fr) * 1993-01-19 1994-08-04 The Gillette Company Bain de bouche
EP0671175A2 (fr) * 1989-11-17 1995-09-13 The Procter & Gamble Company Compositions pharmaceutiques à libération prolongée pour le traitement des maladies périodontales
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058564A (en) * 1979-09-07 1981-04-15 Horton J E Pharmaceutical compositions comprising anti-osteoporotic agents
EP0345039A2 (fr) * 1988-05-31 1989-12-06 AMER & COMPANY, INC. Procédé et composition pour le traitement ou la prévention de la plaque ou du tartre dentaires ou de la gingivite
EP0671175A2 (fr) * 1989-11-17 1995-09-13 The Procter & Gamble Company Compositions pharmaceutiques à libération prolongée pour le traitement des maladies périodontales
EP0455503A1 (fr) * 1990-05-04 1991-11-06 Colgate-Palmolive Company Composition pour le traitement de l'ostéoporose et du déséquilibre hormonal
US5310545A (en) * 1991-04-11 1994-05-10 Drore Eisen Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter
WO1994016673A1 (fr) * 1993-01-19 1994-08-04 The Gillette Company Bain de bouche
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism
US9132089B2 (en) 2000-08-30 2015-09-15 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Also Published As

Publication number Publication date
AU4825200A (en) 2000-11-21
WO2000067708A2 (fr) 2000-11-16

Similar Documents

Publication Publication Date Title
WO2001070208A3 (fr) Therapie par remplacement d'hormones
HUP0104718A3 (en) Micronized eplerenone compositions, process for their preparation and use thereof for the preparation of pharmaceutical compositions
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
EP0841936A4 (fr) Compositions d'agents therapeutiques de conjugaison stabilises, formulation d'administration et de diagnostic les contenant
ITMI961152A0 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
DK0748190T3 (da) Progestogenfrie formuleringer af GnRH og estrogen til behandling af benigne gynækologiske lidelser
WO2000042992A3 (fr) Compositions pour administration par les muqueuses et procedes associes
HUP9903515A3 (en) 21-substituted progesterone derivatives as new antiprogestational agents medicoments containing the same, use thereof
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
AU5181200A (en) Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
EP1186293A3 (fr) Administration intermittente d'un secretagogue d'hormone de croissance
WO1999063976A3 (fr) Traitement de diabetes
HUP0201872A3 (en) Steroid compounds and pharmaceutical compositions of the same
AU6152200A (en) Azolylbenzamides and analogues and their use for treating osteoporosis
WO2002074292A3 (fr) Therapie de remplacement d'hormones
AU1460801A (en) Cholesterol reducing sterol compositions, preparation and method of use
WO2001043733A3 (fr) Compositions, trousses, appareil et procedes utiles pour inhiber l'inflammation cephalique
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
ZA200308221B (en) Pharmaceutical compositions for oral and topical administration.
HUP0200173A2 (en) Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne
AU4392199A (en) Medicinal compositions for treating evacuatory insufficiency
AU5252698A (en) Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
ZA200108001B (en) Processes for making pharmaceutical oral ECB formulations and compositions.
WO2001082910A3 (fr) Therapie du cancer
AU2001275707A1 (en) Use of panaxatriol for stimulation angiogenesis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP